Register
Home Quizzes Quiz Detail
Practice Quiz

Arab Board Urology Clinical Exam Practice Questions - Arab Board of Health Specializations Urology Final Clinical and Oral Exam

100 questions 5.0 rating Mobile friendly
$69.00

Unlock the full practice quiz

Get complete access to the questions, explanations and printable quiz resources.

Full access: unlock all quiz questions and explanations.
Printable review: access the full quiz PDF with correct answers after purchase.

About this Exam

Prepare with the Arab Board Urology Clinical Exam Practice Questions - Arab Board of Health Specializations Urology Final Clinical and Oral Exam practice quiz. This question bank includes 100 questions covering year-old, male, renal, reveals, and presents. Use it to review important concepts, identify knowledge gaps, and build confidence for the related exam, course, or assessment.

Sample Questions

Question 1
A 62-year-old male with a baseline PSA of 6.8 ng/mL undergoes multiparametric MRI (mpMRI) of the prostate, which demonstrates a 14 mm PI-RADS 5 lesion in the right peripheral zone with abutment of the capsule but no gross extraprostatic extension. Targeted and systematic transperineal biopsies reveal ISUP Grade Group 2 (Gleason score 3+4=7) adenocarcinoma in 3 targeted cores (maximum core involvement 40%), and all systematic cores from the left lobe are benign. What is the most appropriate next clinical management discussion with this patient?
Immediate initiation of androgen deprivation therapy monotherapy
Discussion of definitive local therapies (radical prostatectomy or external beam radiotherapy) versus carefully monitored active surveillance
Immediate bilateral pelvic lymph node dissection alone as a diagnostic procedure
Systemic chemotherapy with six cycles of docetaxel
Question 2
A 66-year-old male who underwent robot-assisted laparoscopic radical prostatectomy 2 years ago for pT3aN0 prostate cancer with negative surgical margins had an undetectable postoperative PSA (<0.01 ng/mL). Routine surveillance reveals a confirmed PSA rise to 0.24 ng/mL, repeated 3 months later at 0.31 ng/mL. What is the established diagnosis and the standard-of-care next therapeutic step?
Biochemical recurrence; initiate salvage radiation therapy to the prostatic bed with consideration of short-term ADT
Benign anastomotic stricture; schedule urethral dilatation
Castration-resistant prostate cancer; start enzalutamide monotherapy
Widespread bone metastasis; initiate palliative zoledronic acid without imaging
Question 3
A 71-year-old male presents with bone pain and is diagnosed with de novo metastatic hormone-sensitive prostate cancer (mHSPC). Staging 68Ga-PSMA PET/CT demonstrates multiple avid lesions across the lumbar spine, pelvis, and ribs (high-volume disease by CHAARTED criteria), with a baseline PSA of 185 ng/mL and normal organ function. What represents the current evidence-based first-line systemic management?
Triplet systemic therapy with ADT, docetaxel chemotherapy, and an AR pathway inhibitor (darolutamide or abiraterone)
Continuous bicalutamide 50 mg monotherapy
Immediate bilateral open orchiectomy alone without any further systemic agents
External beam radiation therapy to the prostate without systemic therapy
Question 4
During evaluation of a 60-year-old male with mild lower urinary tract symptoms, multiparametric MRI of the prostate demonstrates a 12 mm well-circumscribed, encapsulated, round nodule within the transition zone with heterogeneous T2 signal and no diffusion restriction or focal early enhancement. According to PI-RADS v2.1 guidelines, how should this finding be categorized?
PI-RADS 2 (Clinically significant cancer is unlikely)
PI-RADS 4 (Clinically significant cancer is likely)
PI-RADS 5 (Clinically significant cancer is highly likely)
PI-RADS 1 (Normal background tissue without any distinct nodule)
Question 5
A 64-year-old male with clinically localized prostate cancer (PSA 16 ng/mL, cT2b, ISUP Grade Group 4 [Gleason 4+4=8]) is scheduled for robot-assisted radical prostatectomy. A validated nomogram calculates an estimated pelvic lymph node involvement risk of 22%. What constitutes the standard anatomical template for extended pelvic lymph node dissection (ePLND) in this patient?
Removal of external iliac, obturator fossa, and internal iliac (hypogastric) nodal packets up to the common iliac bifurcation bilaterally
Removal of superficial inguinal and femoral canal lymph nodes only
Sampling of the fat pad overlying the anterior bladder neck exclusively
Excision of retroperitoneal paracaval and para-aortic lymph nodes only

Ready to test your knowledge?

Buy Now to Access

Additional Information

Arab Board Urology Clinical Exam Practice Questions - Arab Board of Health Specializations Urology Final Clinical and Oral Exam

This practice set contains 100 questions from the matching question bank and focuses on year-old, male, renal, reveals, and presents. Work through each question carefully, review the provided solutions, and revisit topics that need more study before your next attempt.

This is an independent study resource intended for practice and review; it is not an official examination or an endorsement by any organization named in the title.

Related Quizzes

10th Brigade Engineer Battalion (10BEB) Board Practice Exam
50 Qs  |  0 Min
1-67 AR Death Dealers Board Practice Test
100 Qs  |  0 Min
1‑502 NCO and Soldier of the Month Board Practice Exam
100 Qs  |  0 Min
Archer Child Health Cardio/Respiratory Practice Exam
86 Qs  |  5 Min
Architectural Planning Board Practice Exam
10 Qs  |  0 Min

Frequently Asked Questions

This quiz contains a total of 100 practice questions carefully selected to test your knowledge on this subject.
Yes, you will have exactly 0 minutes to complete the exam. A countdown timer will be visible once you start.
Yes, you can retake this practice test as many times as you need. The questions and options may be randomized on subsequent attempts to ensure comprehensive learning.

Reviews

5.0

Based on 0 reviews

Leave a Review

No reviews yet. Be the first to review!